☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Horizon Therapeutics
Horizon Therapeutics Reports P-IV Clinical Trial Results of Tepezza (teprotumumab-trbw) for Chronic/Low Clinical Activity Score Th...
April 11, 2023
J.P. Morgan Special: Dealmaker 2022 – Top M&A Deal of Amgen (Part 02)
January 16, 2023
Insights+: The US FDA New Drug Approvals in December 2019 and January 2020
February 21, 2020
PharmaShots Weekly Snapshot (January 20-24, 2020)
January 27, 2020
Top 20 Immunology Companies Based on 2018 Immunology Segment Revenue
August 9, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.
